Machado-Lopez, A.; Alonso, R.; Lago, V.; Jimenez-Almazan, J.; Garcia, M.; Monleon, J.; Lopez, S.; Barcelo, F.; Torroba, A.; Ortiz, S.;
et al. Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma. Int. J. Mol. Sci. 2022, 23, 2190.
https://doi.org/10.3390/ijms23042190
AMA Style
Machado-Lopez A, Alonso R, Lago V, Jimenez-Almazan J, Garcia M, Monleon J, Lopez S, Barcelo F, Torroba A, Ortiz S,
et al. Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma. International Journal of Molecular Sciences. 2022; 23(4):2190.
https://doi.org/10.3390/ijms23042190
Chicago/Turabian Style
Machado-Lopez, Alba, Roberto Alonso, Victor Lago, Jorge Jimenez-Almazan, Marta Garcia, Javier Monleon, Susana Lopez, Francisco Barcelo, Amparo Torroba, Sebastian Ortiz,
and et al. 2022. "Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma" International Journal of Molecular Sciences 23, no. 4: 2190.
https://doi.org/10.3390/ijms23042190
APA Style
Machado-Lopez, A., Alonso, R., Lago, V., Jimenez-Almazan, J., Garcia, M., Monleon, J., Lopez, S., Barcelo, F., Torroba, A., Ortiz, S., Domingo, S., Simon, C., & Mas, A.
(2022). Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma. International Journal of Molecular Sciences, 23(4), 2190.
https://doi.org/10.3390/ijms23042190